期刊文献+

老年人呼吸道革兰阴性杆菌感染耐药机制研究 被引量:21

Resistance Mechanism of Gram-negtive Bacilli from Lower Respiratory Tract of Elderly In-patient
下载PDF
导出
摘要 目的 研究老年人下呼吸道感染革兰阴性杆菌的耐药机制。方法 分别用双纸片增效确认试验 ,改良三维法、自动细菌鉴定和药敏系统 (VITEK)及 Etest方法测定耐药菌产酶情况。结果  80株肺炎克雷伯菌及 14 3株大肠埃希菌产超广谱 β-内酰胺酶 (ESBL s)率分别为 2 7.5 %和 2 8.7% ,CTX- M基因型分别占 4 8%和 5 6 % ;12 4株阴沟肠杆菌中有 2 1.8%单独高产 Amp C酶 ,8.1%单独产 ESBL s,3.2 %即产 ESBL s又高产 Am p C酶 ;71株耐亚胺培南的铜绿假单胞菌中有 18.3%产金属 β-内酰胺酶。结论 产 ESBL s、高产 Amp C酶和金属 β-内酰胺酶是住院老年患者下呼吸道感染的重要因素。 OBJECTIVETo investigate the resistance mechanism of G- bacteria from lower respiratory tract in elderly. METHODSDouble-disk test, three-dimensional extract test, VITEK and Etest were performed. RESULTS Among 80 strains of Klebsiella pneumoniae (27.5%) and 143 strains of Escherichia coli (28.7%) produced ESBLs, CTX-M accounted for 48% and 56%, respectively. Among 124 strains of Enterobacter cloacae isolates, 21.8% only produced high-level AmpC β-lactamases, 8.1% only produced ESBLs, 3.2% produced both high-level AmpC β-lactamases and ESBLs. Among 71 strains of Pseudomonas aeruginosa resistant to imipenem, 18.3% produced metallo-β-lactamases. CONCLUSIONS The result showed that the strains produced extended spectrum β-lactamases (ESBLs), high-level AmpC β-lactamases and metallo-β-lactamases are important causes for lower respiratory infection in the elderly in-patients.
机构地区 卫生部北京医院
出处 《中华医院感染学杂志》 CAS CSCD 2004年第1期94-96,共3页 Chinese Journal of Nosocomiology
关键词 老年人 下呼吸道感染 革兰阴性杆菌 耐药机制 Elderly Lower respiratory tract infection Gram-negative bacilli Resistance mechanism
  • 相关文献

参考文献12

二级参考文献30

  • 1蔡少华.气管导管细菌生物被膜在呼吸机相关肺炎发病机制中的作用[J].药物与临床,2000,15(1):28-31.
  • 2Jacoby GA, Medeiros AA. More extended spectrum β-lactamase[J]. Antimicrob Agents Chemother, 1991, 35(9): 1697.
  • 3Sanders CC, Barry AL, Washington JA, et al. Detection of extended-spectrum β-lactamase-producing members of the family Enterobacteriaceae with the VITEK ESBL test[J]. J Clin Microbiol, 1996, 34(12): 2997.
  • 4Jarlier V, Nicolas MH, Fournier G, et al. Extended broad-spectrum β-lactamase conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns[J]. Rev Infect Dis , 1988, 10(4): 867.
  • 5Livermore DM. β-Lactamase in laboratory and clinical resistance[J]. Clin Microbiol Rev, 1995, 8(4): 557.
  • 6Tseng CY,Liu PY,Wu WL,et al.Comparison of detection of extended-spectrum beta-lactamases by agar dilution method,E-test ESBL screen and double disk test[J].J Microbiol Immunol Infect 1998,31(2):90-94.
  • 7Sirot D.Extended-spectrum plasmid-mediated β-lactamases[J].J Antimicrob Chemot her,1996,(SupplA):19-34.
  • 8Liu PYF,Tung JC,Ke SC,et al.Molecular epidemiology of extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates in a district hospital in Taiwan[J].Clin Microbiol,1998,36:2759-2762.
  • 9Bush K,Jacoby GA,Medeiros AA.A functional classification scheme for β-lactamases and its correlation with molecular structure[J].Antimicrob Agents Chemother,1995,39:1211-1233.
  • 10阮良,徐秀华,文细毛.克雷伯氏菌 β-内酰胺酶的测定及其与耐药质粒的关系[J].中华医院感染学杂志,1997,7(2):72-74. 被引量:39

共引文献539

同被引文献87

引证文献21

二级引证文献151

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部